The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
disopyramide phosphate · Powder
3 marketed package NDCs · 3 active manufacturers
Most dispensed: 100 mg · Capsule · #100 capsules/bottle · 150 mg · Capsule · #100 capsules/bottle · 150 mg · Capsule, Gelatin Coated · #100 capsule, gelatin coateds/bottle · 100 mg · Capsule, Gelatin Coated · #100 capsule, gelatin coateds/bottle
What changed in the last 90 days
Every detected change for disopyramide phosphate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Norpace CRSep 2, 2026Mfr exitedPfizer Laboratories Div Pfizer Inc · disopyramide phosphate
- Norpace CRSep 2, 2026Mfr exitedPfizer Laboratories Div Pfizer Inc · disopyramide phosphate
- Norpace CRAug 27, 2026New shortageby this manufacturerPfizer Inc.'s Norpace CR (Capsule, Extended Release, 100 mg) is newly in shortage7 companies market norpace cr
- Norpace CRAug 27, 2026New shortageby this manufacturerPfizer Inc.'s Norpace CR (Capsule, Extended Release, 150 mg) is newly in shortage7 companies market norpace cr
- Disopyramide PhosphateAug 19, 2026Price downNADAC $0.85936 → $0.85063 per unit (-1.02%)
- Disopyramide PhosphateAug 19, 2026Price downNADAC $1.53542 → $1.50064 per unit (-2.27%)
- Disopyramide PhosphateAug 19, 2026Price downNADAC $1.53542 → $1.50064 per unit (-2.27%)
- Disopyramide PhosphateAug 19, 2026Price downNADAC $0.85936 → $0.85063 per unit (-1.02%)
- Disopyramide PhosphateAug 19, 2026Price downNADAC $1.53542 → $1.50064 per unit (-2.27%)
- Disopyramide PhosphateAug 19, 2026Price downNADAC $0.85936 → $0.85063 per unit (-1.02%)
Same drug class
Other molecules FDA puts in Antiarrhythmic, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- lidocaine hydrochloride anhydrous and dextrose monohydrate· in shortage
- lidocaine hydrochloride anhydrous· in shortage
- lidocaine hydrochloride,epinephrine bitartrate· in shortage
- lidocaine hydrochloride and epinephrine· in shortage
- lidocaine hydrochloride· in shortage
- lidocaine· in shortage
- 0.5% lidocaine hcl· 1 maker
- 1% lidocaine hci· 1 maker
- 1168 burn spray· 1 maker
- 2.5% lidocaine hcl· 1 maker
- 2677 first aid burn cream· 1 maker
- 4% lidocaine numbing cream· 1 maker
Common questions
- Is Disopyramide phosphate in shortage right now?
- No. FDA does not currently list Disopyramide phosphate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Disopyramide phosphate?
- 7 companies have marketed Disopyramide phosphate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Disopyramide phosphate cost?
- The typical pharmacy pays about $0.8506 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.